Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,110 | 4,740 | 9,368 | 9,228 | 10,456 |
| Marketable Securities | 7,691 | 11,212 | 10,492 | 12,216 | 16,207 |
| Receivables | N/A | 885 | 1,037 | 922 | N/A |
| TOTAL | $13,455 | $16,837 | $20,897 | $22,366 | $27,705 |
| Non-Current Assets | |||||
| PPE Net | 276 | 289 | 303 | 319 | 338 |
| Other Non-Current Assets | 813 | 883 | 951 | 733 | 806 |
| TOTAL | $1,089 | $1,172 | $1,254 | $1,052 | $1,144 |
| Total Assets | $14,544 | $18,009 | $22,151 | $23,418 | $28,849 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,113 | 527 | 516 | 731 | 2,347 |
| Accrued Expenses | 3,086 | 3,401 | 3,423 | 3,007 | 2,503 |
| Other current liabilities | N/A | 360 | 823 | 1,527 | 1,867 |
| TOTAL | $4,308 | $4,398 | $4,838 | $5,370 | $6,825 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 251 | 280 | 316 | 5 | 33 |
| TOTAL | $251 | $280 | $316 | $5 | $33 |
| Total Liabilities | $4,559 | $4,678 | $5,154 | $5,375 | $6,858 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 3,551 | N/A | N/A |
| Retained earnings | -96,177 | -92,546 | -88,678 | -84,623 | -80,542 |
| Other shareholders' equity | 0 | 0 | 0 | -218 | -218 |
| TOTAL | $9,985 | $13,331 | $16,997 | $18,043 | $21,991 |
| Total Liabilities And Equity | $14,544 | $18,009 | $22,151 | $23,418 | $28,849 |